CYTOKINETICS, INCORPORATED (CYTK) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $138.00K; Additional Paid in Capital, Common StockUSD $3.72B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-3.83M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $124.00K; Additional Paid in Capital, Common StockUSD $2.87B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.61M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $123.00K; Additional Paid in Capital, Common StockUSD $2.83B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $630.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $122.00K; Additional Paid in Capital, Common StockUSD $2.78B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $34.00K.
CYTOKINETICS, INCORPORATED Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Stock Split USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $138.00K | $3.72B | $-3.83M | $-3.89B | $-173.49M | 3 month · $36.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $124.00K | $2.87B | $-1.61M | $-3.69B | $-826.57M | 3 month · $30.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $123.00K | $2.83B | $630.00K | $-3.49B | $-659.62M | 12 month · $112.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $122.00K | $2.78B | $34.00K | $-3.30B | $-521.12M | 3 month · $30.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $119.00K | $2.63B | $-158.00K | $-3.00B | $-368.72M | 3 month · $27.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $119.00K | $2.60B | $1.54M | $-2.86B | $-266.41M | 3 month · $23.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $118.00K | $2.56B | $2.40M | $-2.70B | $-135.37M | 12 month · $97.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $118.00K | $2.53B | $5.39M | $-2.55B | $-13.91M | 3 month · $25.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $117.00K | $2.50B | $-1.02M | $-2.39B | $108.55M | 3 month · $24.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $105.00K | $1.85B | $-539.00K | $-2.25B | $-396.16M | 3 month · $21.61M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $102.00K | $1.73B | $-10.00K | $-2.11B | $-386.32M | 12 month · $72.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $94.00K | $1.54B | $-874.00K | $-1.98B | $-438.80M | 3 month · $18.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $94.00K | $1.51B | $-1.46M | $-1.85B | $-333.12M | 3 month · $18.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $94.00K | $1.49B | $-1.65M | $-1.72B | $-229.02M | 3 month · $15.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $94.00K | $1.48B | $-3.59M | $-1.59B | $-107.90M | 12 month · $47.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $93.00K | $1.44B | $-5.56M | $-1.45B | $-15.98M | 3 month · $13.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $85.00K | $1.42B | $-4.49M | $-1.31B | $111.41M | 3 month · $12.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $85.00K | $1.41B | $-3.59M | $-1.29B | $116.26M | 3 month · $8.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-01-01 | (m) | (m) | (m) | (m) | $-1.20B | (m) | (m) | $1.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $84.00K | $1.45B | $-869.00K | $-1.21B | $243.86M | 12 month · $26.83M | $1.45B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $84.00K | $1.43B | $-65.00K | $-1.18B | $249.02M | 3 month · $7.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $72.00K | $1.12B | $-22.00K | $-1.10B | $16.49M | 3 month · $7.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $71.00K | $1.11B | $50.00K | $-1.04B | $67.85M | 3 month · $5.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $70.00K | $1.11B | $149.00K | $-992.31M | $113.38M | 12 month · $17.62M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $184.00K | (m) |
| 2020-09-30 | $0.00 | $70.00K | $1.10B | $958.00K | $-948.38M | $149.60M | 3 month · $4.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $60.00K | $865.72M | $1.34M | $-945.20M | $-78.08M | 3 month · $4.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $59.00K | $857.04M | $1.61M | $-904.42M | $-45.71M | 3 month · $3.52M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $184.00K | (m) |
| 2019-12-31 | $0.00 | $59.00K | $853.34M | $679.00K | $-865.02M | $-10.94M | 12 month · $10.76M | (m) | 12 month · $49.48M | (m) | (m) | (m) | (m) | 12 month · $185.00K | (m) |
| 2019-09-30 | $0.00 | $59.00K | $813.73M | $719.00K | $-834.38M | $-19.87M | 3 month · $2.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $58.00K | $799.09M | $761.00K | $-804.80M | $-4.90M | 3 month · $2.82M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $185.00K | (m) |
| 2019-03-31 | $0.00 | $55.00K | $775.40M | $606.00K | $-772.69M | $3.37M | 3 month · $2.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $55.00K | $768.70M | $500.00K | $-743.32M | $25.93M | 12 month · $9.76M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $182.00K | (m) |
| 2018-09-30 | $0.00 | $55.00K | $765.97M | $447.00K | $-714.40M | $52.07M | 3 month · $2.57M 9 month · $7.48M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $182.00K 9 month · $182.00K | (m) |
| 2018-06-30 | $0.00 | $55.00K | $762.89M | $450.00K | $-688.22M | $75.17M | 3 month · $2.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $54.00K | $757.40M | $489.00K | $-658.35M | $99.60M | 3 month · $2.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $54.00K | $755.53M | $343.00K | $-646.08M | $109.84M | 12 month · $9.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $54.00K | $752.15M | $426.00K | $-605.60M | $147.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $53.00K | $748.27M | $-86.00K | $-573.24M | $175.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $43.00K | $639.51M | $-9.00K | $-544.16M | $95.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $41.00K | $612.47M | $137.00K | $-518.29M | $94.36M | 12 month · $7.15M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $288.00K | (m) |
| 2016-09-30 | $0.00 | $41.00K | $609.88M | $252.00K | $-525.45M | $84.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $40.00K | $607.29M | $229.00K | $-558.81M | $48.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $40.00K | $604.91M | $156.00K | $-547.20M | $57.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $40.00K | $603.14M | $149.00K | $-534.74M | $68.59M | 12 month · $4.57M | (m) | (m) | (m) | (m) | (m) | 12 month · $139.00K | 12 month · $282.00K | (m) |
| 2015-09-30 | (m) | $39.00K | $592.76M | $16.00K | $-525.51M | $67.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $39.00K | $591.48M | $12.00K | $-516.67M | $74.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $39.00K | (m) | $-6.00K | $-506.12M | $84.15M | (m) | $590.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $39.00K | $589.27M | $-4.00K | $-497.24M | $92.06M | 12 month · $3.33M | $589.27M | (m) | (m) | (m) | (m) | 12 month · $139.00K | (m) | (m) |
| 2014-09-30 | (m) | $37.00K | (m) | $24.00K | $-505.69M | $73.63M | (m) | $579.25M | (m) | (m) | (m) | (m) | 9 month · $139.00K | (m) | (m) |
| 2014-06-30 | $0.00 | $37.00K | (m) | $12.00K | $-499.71M | $78.70M | (m) | $578.36M | (m) | (m) | (m) | (m) | 6 month · $139.00K | (m) | (m) |
| 2014-03-31 | (m) | $36.00K | (m) | $12.00K | $-491.34M | $86.18M | (m) | $577.47M | (m) | (m) | (m) | (m) | 3 month · $139.00K | (m) | (m) |
| 2013-12-31 | $0.00 | $31.00K | (m) | $7.00K | $-482.60M | $54.44M | 12 month · $3.60M | $537.00M | (m) | (m) | (m) | (m) | 12 month · $139.00K | (m) | (m) |
| 2013-09-30 | (m) | $29.00K | (m) | $19.00K | $-489.13M | $39.75M | (m) | $528.83M | (m) | (m) | (m) | (m) | 9 month · $139.00K | (m) | (m) |
| 2013-06-30 | (m) | $29.00K | (m) | $-1.00K | $-476.54M | $51.99M | (m) | $528.50M | (m) | (m) | (m) | (m) | 6 month · $139.00K | (m) | (m) |
| 2013-03-31 | (m) | $147.00K | (m) | $10.00K | $-461.50M | $58.43M | (m) | $519.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $24.00K | (m) | $18.00K | $-448.88M | $70.08M | 12 month · $3.78M | $518.92M | (m) | (m) | (m) | (m) | (m) | 12 month · $13.76M | (m) |
| 2012-09-30 | (m) | $142.00K | (m) | $13.00K | $-437.42M | $80.60M | (m) | $517.87M | (m) | 9 month · $4.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $133.00K | (m) | $-1.00K | $-427.38M | $89.98M | (m) | $517.23M | (m) | 6 month · $4.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $78.00K | (m) | $-2.00K | $-418.44M | $42.01M | (m) | $460.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $75.00K | (m) | $3.00K | $-408.51M | $48.18M | 12 month · $3.07M | $456.61M | (m) | (m) | (m) | 12 month · $0.00 | (m) | 12 month · $4.43M | (m) |
| 2011-09-30 | (m) | $72.00K | (m) | $8.00K | $-396.63M | $56.74M | (m) | $453.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $0.00 | $72.00K | (m) | $15.00K | $-385.99M | $66.65M | (m) | $452.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $67.00K | (m) | $-4.00K | $-360.65M | $70.52M | 12 month · $4.02M | $431.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $101.43M | 12 month · $4.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $20.00K |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $49.77M | 12 month · $5.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | $99.92M | 12 month · $4.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | $106.31M | 12 month · $3.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2005-12-31 | (m) | (m) | (m) | (m) | (m) | $73.56M | 12 month · $67.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2004-12-31 | (m) | (m) | (m) | (m) | (m) | $107.56M | 12 month · $278.00K | (m) | (m) | 12 month · $9.15M | (m) | (m) | (m) | (m) | (m) |
| 2003-12-31 | (m) | (m) | (m) | (m) | (m) | $-92.03M | 12 month · $158.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2002-12-31 | (m) | (m) | (m) | (m) | (m) | $-60.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2001-12-31 | (m) | (m) | (m) | (m) | (m) | $-37.35M | (m) | (m) | (m) | (m) | 12 month · $20.00K | (m) | (m) | (m) | (m) |
| 2000-12-31 | (m) | (m) | (m) | (m) | (m) | $-21.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1999-12-31 | (m) | (m) | (m) | (m) | (m) | $-9.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $41.00K | (m) |
| 1998-12-31 | (m) | (m) | (m) | (m) | (m) | $-2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |